A Novel Oxidovanadium (IV)-Orotate Complex as an Alternative Antidiabetic Agent: Synthesis, Characterization, and Biological Assessments

Diabetes is an increasingly common metabolic disorder with high comorbidity and societal and personal costs. Insulin replacement therapy is limited by a lack of oral bioavailability. Recent studies suggest vanadium has therapeutic potential. A newly synthesized complex between oxidovanadium (IV) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Naglah, Ahmed M., Al-Omar, Mohamed A., Almehizia, Abdulrahman A., Bhat, Mashooq A., Afifi, Walid M., Al-Wasidi, Asma S., Al-Humaidi, Jehan Y., Refat, Moamen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323442/
https://www.ncbi.nlm.nih.gov/pubmed/30671472
http://dx.doi.org/10.1155/2018/8108713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323442/
https://www.ncbi.nlm.nih.gov/pubmed/30671472
http://dx.doi.org/10.1155/2018/8108713

Ejemplares similares